4/A
Changes in Ownership
Eloxx Pharmaceuticals, Inc. Filed Acc 0001209191-18-012960
Options or other derivatives
- Chief Financial Officer acquired 399,266 shares (grant or award)
From the SEC's structured data for this filing
Eloxx Pharmaceuticals, Inc. Filed Acc 0001209191-18-012960
Options or other derivatives
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…